Meeting Homepage
Sponsors
Registrants Only Area
Speaker Bios
Meeting Committee
Welcome
Registration:
Registration Info
Register
Hotel Reservations
Meeting Program:
Schedule-at-a-Glance
Add-on Seminars
Plenary Sessions
Mini-Plenary Sessions
Workshops-at-a-Glance
Workshops by Track
Workshops
PDS Workshops
CLE
Leadership Forum
Additional Events:
Networking Events
Tech Fair
Tours and Sports
Accompanying Persons Schedule
Power Networking
Sponsorship:
Meeting Sponsors
Sponsorship Opportunities
Power Networking
Sponsorship Opportunities [PDF]
Tech Fair:
Exhibitor Information
Floor Plan [PDF]
Space Application [PDF]
Poster Application [PDF]
Misc. Info:
Weather and Dress
Transportation
Discount Disney Tickets Speakers Only:
Information
|
Speaker Biographies
Anjan Aralihalli
Anjan Aralihalli, MBA is a Director Business Development/US licensing at sanofi-aventis
where he supports the in-licensing of late-stage and commercial products for
the US commercial organization. Anjan or “AJ” has
over 15 years of experience in the CRO, biopharma and pharmaceutical industries
with varying roles of increasing responsibility ranging from clinical study
management, sales, marketing, corporate finance, business development and strategic
planning. AJ holds an MBA from Queen's University and earned his
B.Sc. in Exercise Science from Concordia University.
[back to top]
Richard Baker, CLP
Richard Baker, CLP, is the Director of Intellectual Property Licensing for 3Com Corporation. Since joining 3Com, Mr. Baker has been involved in a number of licensing projects and in the management of existing licenses for 3Com.
Rich Baker is also running for a seat in the United States House of Representatives for the Massachusetts 6th Congressional District (North of Boston).
Prior to joining 3Com, Mr. Baker was the Director of Intellectual Property at Schneider Automation. Mr. Baker is an inventor on 15 patents in the Web, embedded Ethernet, and business method areas for his work at Schneider.
Mr. Baker's graduate studies include Intellectual Property at Franklin Pierce Law Center and Computer Science at Harvard University. He holds a bachelor's degree in Computer Science and English as a dual major at the University of New Hampshire.
Mr. Baker resides with his wife and son in West Newbury, Massachusetts.
[back to top]
Scott Bechtel
Scott Bechtel has over 25 years of experience in high technology product development
and commercialization, including patent portfolio management. His career
has included technical, marketing, and management positions with AT&T,
RCA, TRW, and Maxtek/Tektronix. Scott has helped found three successful
start-ups and managed a business incubator including 7 early stage technology
companies. He has also held key IP management positions with Competitive Technologies
(University Patents) and TAEUS. Scott is author of a popular engineering
textbook on Optoelectronics and holds 4 US patents. He is a Hawk Award and
Eagle Award winner for Department of Defense Program Management and an Eagle
Scout. His bachelor's degree is in physics with additional coursework
in biology and electrical engineering, and he holds a Masters of Science in
Industrial Administration with Distinction from Carnegie Mellon University.
[back to top]
Louis P. Berneman
Lou Berneman is an experienced intellectual property licensing
and business development executive. He has founded and financed entrepreneurial
ventures and has built and managed a university technology transfer program.
Currently, Lou is the Principal of Texelerate, a development-stage
intellectual property trading company.. Since September 2005, Texelerate
has been functioning as a consultancy specializing in academic-industry technology
commercialization. Texelerate clients include academic research institutions
and teaching hospitals, companies and law firms. Berneman is a consultant
to and member of the Strategic Advisory Board of the Paul Capital Partners
Royalty Healthcare Funds.
Berneman is a Past President of the Association of University
Technology Managers (AUTM) and a former Vice President and Trustee of the
Licensing Executives Society (LES USA & Canada). He has served
as a member of the Board of the Pennsylvania Biotechnology Association, Greater
Philadelphia Venture Group and the LES Foundation. Dr. Berneman is the
2005 recipient of the LES Barnes Mentoring Award and a 2003 recipient of an
Award of Excellence from the Association of University Research Parks.
From 1995-2005, Dr. Berneman was Managing Director of the
Center for Technology Transfer (CTT) at the University of Pennsylvania. Under
his leadership, CTT became one of the most productive university technology
licensing offices in the world:
- filing more than 1500
patents,
- consummating more than
600 option/license agreements,
- launching more than
80 new start up ventures, and
- generating more than
$100 million in license income.
From 1989-1995, Berneman was Director, Licensing and Business
Development at Virginia's Center for Innovative Technology. From 1984-1989,
he founded and served as President and CEO of Biotherapeutics, Inc., a provider
of cancer biotherapy services. He also helped found and served as a Director
of Innotech, Inc., an ophthalmic manufacturing system. From 1982-1984, he
was VP of Marketing and Sales of Immuno-Modulators Laboratories, Inc., an
emerging biopharmaceuticals company. From 1976-1982, he was Assistant Professor
of Education at University of Houston.
Dr. Berneman holds a baccalaureate degree in history from
the Pennsylvania State University, a teaching credential from University of
California at Santa Barbara, and masters and doctoral degrees in education
from Teachers College, Columbia University.
[back to top]
Donald M. Boles
Mr. Boles earned his Bachelors degree in Electrical Engineering and his Juris Doctor from the University of Dayton in 1976 and 1979 respectively. He started his career in law at Westinghouse, moving to AMP in 1982 where he handled all of the company’s Pacific Rim IPR activities. In 1992, he began work for Siemens Corporation handling several large business units. In 1997, Don became the Vice President of Intellectual Property for InterDigital Communications Corporation. InterDigital is a recognized pioneer in the architecture, design, and delivery of advanced wireless technology platforms. He has since been promoted to Senior Vice President level holding the title of Chief Patent Strategist and also holds the position of Vice President of Intellectual Property and Chief Patent Counsel of InterDigital Technology Corporation, a subsidiary that holds issued and pending patents and is a member of the board of Directors for IPR Licensing and Tantivy Communications. As a member of LES he is also a Certified Licensing Professional.
During his tenure at InterDigital, the company has grown the patent portfolio over tenfold with 163 US Patents issuing in 2007 making it approximately 122 in the world for the most issued patents in 2007. He is integral in developing and executing licensing strategies of the patent portfolio. He is very active in Asia, traveling there monthly engaging industry and government groups for the purpose of licensing the companies patent portfolio.
[back to top]
Russell Boltwood
Russell Boltwood joined UTStarcom in December 1997 as its first Director of Law and Human Resources. He oversaw the Company's legal and human resources functions through its successful IPO in 2000, as well as through its expansion into India, Japan, Europe and South America. In 2007, Russell became the Company's first Vice President of Licensing and Intellectual Property, and presently oversees the Company's patent and intellectual property licensing matters. Russell holds a B.A. in Economics from the University of California, Berkeley, a J.D. from Golden Gate University in San Francisco, and is a graduate of the Executive Program at Stanford University's Graduate School of Business in Palo Alto, California. Russell is a member of the State Bar of California, and has authored a number of articles regarding intellectual property, including "Basic Patent Law in Brazil, And Recent Developments," an article published in the January 2008 edition of the International In-House Counsel Journal (www.iicj.net). Russell also provides regular comment on IP development and management issues via his blog at www.ip-transactions.typepad.com.
[back to top]
Ben Bonifant
Ben Bonifant is an experienced consultant to leaders of global pharmaceuticals and biotechnology organizations and to decision makers of large private equity funds. Mr. Bonifant has been a management consultant for more than fourteen years. His perspectives on developments in the life sciences market are frequently published in industry and strategy journals. Recent by-lined articles have appeared in Pharmaceutical Executive, Chemical Specialties, and Business Horizons. He is the author of the chapter, "Market Segmentation and New Product Development" in the recent update to The PDMA Handbook of New Product Development. In addition, Mr. Bonifant has written case studies on the pharmaceutical industry used in graduate business programs. He has been a guest lecturer at the Fuqua School of Business, the Indiana University Kelly School of Business, and many industry conferences in the US and Europe. Mr. Bonifant earned an M.B.A. from the Stanford Graduate School of Business and a B.S. in mechanical engineering from Duke University.
[back to top]
Timothy R.M. Bryant
Timothy R.M. Bryant is a partner in the law firm of McDermott Will & Emery LLP based in the Firm's Chicago office.
Tim has a national corporate transactional practice. He focuses on mergers and acquisitions, leveraged buyouts, venture capital and royalty financings, public securities offerings and counseling, and the formation of and investment in private equity funds.
Tim's clients include public and private companies, as well as the investment banks, private equity, venture capital and hedge funds, and other financial institutions that support them. Tim has particular expertise representing senior executives and management teams in their equity and compensation arrangements. Tim also represents many of the Firm's largest families and family offices in their transactional matters.
For several years, Tim led the Firm's corporate practice in Silicon Valley, where he counseled venture capital funds and information technology and biotechnology companies in a wide variety of transactions.
Tim is recognized as one of the leading corporate lawyers in the United States by many legal directories. Chambers & Partners USA ranks Tim as a leading private equity lawyer. Who's Who Legal rates Tim as one of the top 20 M&A lawyers in Chicago. Tim has also been cited in Corporate Counsel, Illinois Super Lawyers, The Best Lawyers in America and Leading Lawyers Network. Tim is a frequent writer and speaker on a wide variety of corporate and securities topics.
Tim is a member of the boards of directors of The Lawyer's Club of Chicago, the Chicago Debate Commission, Montgomery Place, and the Church Home. He is also a member of The Economic Club of Chicago.
At Northwestern University School of Law, Tim served as an editor of the Law Review. Prior to private practice, Tim clerked for the Honorable James B. Zagel of the U.S. District Court for the Northern District of Illinois.
Education
- Northwestern University School of Law, J.D., 1989
- Northwestern University, B.A., 1986
[back to top]
Susan A. Capello
Susan A. Capello is a Senior Intellectual Property Attorney for Intel Corporation. She graduated from West Chester University of Pennsylvania with a Bachelor of Science in Chemistry/Biology and Business Administration and worked in scientific research capacities with Hoffman-LaRoche, Inc. and the Rorer Group, Inc. . Ms. Capello received her Juris Doctor from Pace University School of Law in 1989 and spent several years in private practice before becoming an in-house IP attorney. As in-house counsel she has worked for Becton, Dickinson and Company; Lipid Sciences, Inc. and Connetics Corporation.
[back to top]
Mary Ann Capria, Esquire
Mary Ann Capria, Corporate Counsel for DuPont Legal, has over 24 years experience in all aspects of Intellectual Property and Commercial law. She has represented a wide variety of companies to achieve a wide variety of business goals - from start-ups, recent IPO, to companies in the Fortune 100, involving many technologies (IT, software, life sciences, chemical arts, electrical arts, and mechanical arts).
Her experience includes:
- Clerk, U. S. Court of Appeals for the Federal Circuit
- Fellow, Kyoto Comparative Law Center, Kyoto, Japan
- Private Practice: All aspects of patent preparation and prosecution, licensing, development agreements, alliances, opinions, counseling, due diligence, and complex litigation (Federal courts, ITC, arbitration, and mediation with respect to patents, trademarks, trade secrets, and licenses), mergers and acquisitions, and other commercial transactions.
- Finnegan, Henderson, Farabow, Garrett & Dunner (DC office)
- Jones Day Reavis and Pogue ( DC office)
- Birch Steward Kolash & Birch (VA office)
- Alston & Bird (DC office) - Technology Practice Group and DC Office’s, Chair of Life Science Group
[back to top]
Linda Chao
Linda Chao is a Senior Licensing Associate in Stanford University's Office
of Technology Licensing and a registered patent agent. She manages a portfolio
of over 300 inventions, including nanotechnology, photonic, semiconductor, and bioengineering technologies, and negotiates licenses with companies
ranging from start-up ventures to Fortune 500 companies. She is the OTL
representative to the Stanford Entrepreneurship Network. Linda is also
an active member of the Licensing Executives Society (LES). Her technical
and business experience includes microprocessor design at Digital Equipment
Corporation, industry analysis at SEMATECH, and product marketing at Applied
Materials. Linda received a Bachelor of Science in Electrical Engineering, a Master of Science in Electrical Engineering, and a Master of Science
in Management from Massachusetts Institute of Technology.
[back to top]
Mitchell Charness
Mitchell Charness is a partner of Ridout & Maybee LLP in the firm's Ottawa
office. His practice covers mechanical patents, trade-marks, licensing and litigation. He
has appeared numerous times before the Federal Court, the Federal Court of Appeal
and the Trade-marks Opposition Board. Mitch was called to the Bar in Ontario
in 1995 and prior to joining private practice, he clerked with the Federal Court
of Canada.
Mitch has a B.A.Sc. in Mechanical Engineering from the University of Waterloo
and an LL.B. from the University of Ottawa.
He is also a part-time Professor at the University of Ottawa Law School,
teaching a course in Advanced Trade-marks law and is a frequent speaker on
intellectual property topics for various organizations, including the University
of Ottawa School of Engineering, Carleton University, Algonquin College,
the National Judicial Institute and the Canadian Intellectual Property Office.
[back to top]
Hugh M. Cole
Hugh Cole joined Shire in April 2007 as Vice President of Business Development for Shire HGT. While at Shire, Hugh has led three major in-licensing/acquisition transactions – with Amicus Therapeutics, Zymenex, and Jerini AG. Prior to joining Shire, Hugh was Vice President of Corporate Development at Oscient Pharmaceuticals and, prior to that, held business development and new business planning roles at Millennium Pharmaceuticals. Hugh has completed numerous transactions in his business development career, including in-licensing, out-licensing, co-promotion, and merger/acquisition transactions. Before joining the biopharmaceutical industry, Hugh spent several years in the investment management and management consulting fields.
Education
AB (Chemistry), Harvard University
MBA (Finance and Health Care Management), The Wharton School, University of Pennsylvania
[back to top]
Dr. Teresa Colella
Dr. Teresa Colella is a Technology Manger at the Applied Physics Laboratory.
Previously, she worked for over four years as a Registered Patent Agent at
Sterne, Kessler, Goldstein and Fox. Dr. Colella carried out post-doctoral
research at Johns Hopkins School of Public Health, obtained her Ph.D. in Microbiology/Immunology
at the University of Virginia, and her B.A. from Wellesley College. She
is an MBA candidate at Loyola College.
[back to top]
Walter G. Copan
Dr. Walter G. Copan is Executive Vice President - North American Operations and Chief Technology Officer for Clean Diesel Technologies, Inc., Stamford, Connecticut, U.S.A. The focus of this role is bringing clean energy, energy efficiency and environmental technologies to global transportation and distributed power markets. He was previously Principal Licensing Executive at the National Renewable Energy Laboratory (NREL) of the U.S. Department of Energy. There his responsibilities included the licensing and commercialization of energy related technologies, new enterprise development, and partnerships with industry, academia and government.
Prior to joining NREL, Dr. Copan was Managing Director, Technology Transfer and Licensing for The Lubrizol Corporation, responsible for corporate venturing and new business development. Previous assignments in Dr. Copan's 28 year career with Lubrizol include leadership roles in research, product development, strategy, new ventures, business development and commercial management. He also headed Lubrizol Petroleum Chemicals Technology based in the U.K., with responsibility for product development, program management and technical service for Lubrizol's business in Europe, the Middle East, Africa and the Former Soviet Union.
He received his Ph.D. in Physical Chemistry from Case Western Reserve University, and his undergraduate degrees from CWRU are in chemistry and music. He has authored numerous professional publications and presentations, and serves on the boards of directors for several organizations. Dr. Copan has been an active member, committee chair, trustee, and officer of the Licensing Executives Society (LES) USA & Canada and LES International. He currently is LES Vice-President, U.S.A. Region, and within LESI is Chair of the Industry-University and Government Transactions committee. He also served as member of the National Advisory Council to the U.S. Federal Laboratory Consortium. Other professional associations include the Society of Automotive Engineers and the American Chemical Society.
[back to top]
John Cosmopoulos
John Cosmopoulos has worked at Tufts University since September 2001 as Senior
Manager, Business Development in the Office for Technology Licensing & Industry
Collaboration where he is the primary case manager for the Schools of Medicine
and Dental Medicine and also manages projects for the Schools of Veterinary
Medicine and Nutrition. In this capacity, he manages all aspects of the technology
transfer process from faculty outreach, evaluation of new invention disclosures,
marketing, negotiations, agreement drafting and he has successfully concluded
a wide range of option and license agreements, sponsored research agreements,
IP agreements, collaboration agreements, as well as facilitated the formation
of start-up companies. Prior to Tufts University Mr. Cosmopoulos started his
career in technology transfer at the University of Ottawa where in 1996 he
was hired as its first full-time technology transfer professional. Mr.
Cosmopoulos has an undergraduate education in biology from the Aristotle University
of Thessaloniki, Greece and a M.Sc. degree in molecular biology from Carleton
University and a MBA degree from Queen's University.
[back to top]
Luciano Daffarra
Luciano Daffarra is the founding partner of Daffarra & Partners. Before
going into private practice, he was part of the legal offices of big Italian
corporations operating, among others, in the broadcasting field.
As a lawyer, he subsequently represented and currently represents many
producers, distributors and artists active in all media sectors. He is a member
of the Permanent Consultative Committee for Copyright at the Italian
Prime Minister's Office and is Secretary General of the Italian Federation
Against Audio-Visual Piracy (www.fapav.it).
Mr. Daffarra is a also member of the American Chamber of Commerce in Italy
(www.amcham.it ),
as President of the Intellectual Property Committee since 1996, and on the
Board of Directors of the Chamber since 2003. In the above capacities, he
collaborates with the Italian Government offices in charge of enforcing and
drafting amendments to the Italian Copyright Law, and has dealt with major
problems relating to copyright and intellectual property in Italy, the European
Union and the United States.
Mr. Daffarra is a frequent speaker and lecturer at courses, seminars and
conferences dealing with intellectual property law. He is a founding
member of the Italian organizations AGICA (Association of Cinema and Audio-Visual
Lawyers) and IPLAW (Association for Intellectual Property Rights and Competition www.iplaw.it)
[back to top]
Pamela Demain
Pamela Demain is Executive Director, Corporate Licensing at
Merck & Co., Inc. She has been at Merck for twenty-five years.
For twelve years, she has been responsible for negotiating transactions
with companies, universities and institutions worldwide, including
arrangements for compounds, research collaborations, patents, formulations
and research platform technologies. Pam also heads up the relationship
development area, which involves initiating new business development
opportunities. Prior to her current position, Ms. Demain was
in charge of the Business Information & Research Group in the Worldwide
Human Health Marketing area of Merck, providing strategic decision
support for new and in-line products.
Previous positions at Merck include Corporate Planning, Marketing Communications
and Product Management, where she was responsible for the worldwide launch
of PRIMAXIN/TIENAM. She joined Merck in 1981 as part of a management
training program.
Pamela's pharmaceutical career began in the natural products laboratory
of Gruppo Lepetit, an Italian pharmaceutical company, which was then a subsidiary
of the Dow Chemical Company. Ms. Demain is a graduate of the University
of Massachusetts at Amherst, and holds a M.B.A. in International Business
from The American University in Washington, D.C.
[back to top]
Jonathan Fleming
Jonathan Fleming is the Managing Partner of Oxford Bioscience Partners,
an international venture capital firm specializing in life science
technology based investments, with offices in Boston and Connecticut. Mr.
Fleming has been in the investment business for over twenty years, starting
and financing growth companies in the United States, Europe, and Israel.
Prior to joining OBP in 1996, he was a Founding General Partner of MVP Ventures
in Boston, MA. He began his investment career with TVM Techno Venture
Management in Munich, Germany. Mr. Fleming has also co-founded Medica Venture
Partners, a venture capital investment firm specializing in early stage healthcare
and biotechnology companies in Israel. Mr. Fleming holds a Master’s
degree in Public Administration from Princeton University and a Bachelor
of Arts degree from the University of California, Berkeley.
Mr. Fleming is a co-founder and member of the Board of Memory Pharmaceuticals
(NASDAQ: MEMY). He is also Chairman of the Board of BioProcessors Corporation
and is a director of several private companies including Leerink Swann,
a Boston based investment bank specializing in healthcare companies. Mr.
Fleming is a Trustee of the Museum of Science in Boston and a Senior Lecturer
at the Massachusetts Institute of Technology.
[back to top]
Joseph D. Fondacaro, PhD
Dr. Fondacaro received his Ph.D. in Physiology from the University of Cincinnati College of Medicine. Following a 2–year postdoctoral fellowship at Albany Medical Center in New York, he spent 8 years as a faculty member at the Cincinnati College of Medicine and 15 years as a scientist and administrator in the pharmaceutical industry initially with what is now Glaxo SmithKline and later with Marion Merrill Dow. In 1996, Dr. Fondacaro joined Cincinnati Children's Hospital Research Foundation to establish the office of technology transfer. He serves on the Board of Trustees for BioStart, a biomedical incubator and the Cincinnati Foundation for Biomedical Research and Education. He holds a faculty position at the University of Cincinnati College of Medicine and lectures on Ethics in Intellectual Property Management. He serves on several AUTM committees and has recently served as the AUTM Vice President for Professional Development. He is past chair for the Industry-University Transactions Sector of the Licensing Executive Society (LES) and co-founder and chairman of the Cincinnati Chapter of LES. He has published relevant articles on university licensing and technology transfer. Dr. Fondacaro is the founder and immediate past Director of the Center for Technology Commercialization and is currently the Executive Director for Strategic Research Alliances for Cincinnati Children’s Hospital Medical Center.
[back to top]
Paul Germeraad
Paul Germeraad is President of Intellectual Assets, Inc., a professional advisory services firm specializing in integrated business, R&D, and IP processes. Intellectual Assets, Inc. is distinguished by using cutting edge IP assessment tools and proprietary software, in addition to offering invaluable insight based on the depth and breadth of executive level management experience and industry coverage the firm's members represent.
Dr. Germeraad was previously Chief Operating Officer for Aurigin Systems, Inc., a software start-up company, where he focused on the development of the company's intellectual asset management products for the Competitive Intelligence, Licensing and R&D communities. Prior to joining Aurigin in 1998, Paul worked for three Fortune 500 companies. He served as Vice President, Corporate Research for Avery Dennison, as the executive responsible for the Corporate Research Center. Before joining Avery Dennison, Paul was director of James River Corporation's Flexible Packaging Technical Center and held a variety of R&D and management positions at Raychem Corporation.
Paul is past Chairman of the Industrial Research Institute, an organization of Chief Technology Officers whose organizations account for over 70% of all US R&D spending. Paul joined the Licensing Executives Society (LES) Board of Trustees in 2002, served as Vice President, Education in 2004, and is chair of the LESI Long Range Planning Committee. He is an instructor for the LES Professional Development Series.
Paul is a graduate of the University of California, San Diego, with a B.A. in Chemistry. In addition, Paul holds a Ph.D. in Chemistry from the University of California, Irvine and an LL.B degree from La Salle Extension University. He has also received the CLP designation from LES USA-Canada.
[back to top]
Andy Gibbs
Andy Gibbs is the Chairman and CEO of PatentCafe, a provider of Latent Semantic Analysis based solutions used for patent search, strategic portfolio management and qualitative patent analysis.
An IP Thought Leader, he was a member of the esteemed panel of participants in Building a New IP Marketplace – the IBM / NY Law School WIKI on policy and process for improving patent quality, transparency, fair valuation, flexibility and global consistency.
He served two terms on the USPTO Public Patent Advisory Committee (PPAC), and served as Chairman, E-government Subcommittee advising on Patent Office IT infrastructure and software tools. He is an immediate past member of the Board of Directors, Intellectual Property Owners Association, and a member of the Licensing Executives Society and Patent Information Users Group. Mr. Gibbs authored the corporate patent strategy book, Essentials of Patents (Wiley), PatentWiter (Sq. One), and more than 100 patent quality and IP management articles.
[back to top]
John P. Gourary
John P. Gourary, co-head of Finance at Covington & Burling LLP, has more than 25 years of experience in structured finance and other asset-based transactions, as well as in mergers and acquisitions and venture capital transactions. He has handled transactions in these areas for, among others, Abbey National, Abbott Laboratories, Charlesbank Capital Partners, Emory University, GE Capital, Genworth, LIN Television, Kerr-McGee, Microsoft, Northwestern University, Resource America, Tronox, UBS, University of Rochester and Zurich Financial Services.
Mr. Gourary's practice has recently centered on innovative financings of unusual asset classes, including, in particular, monetizations of pharmaceutical royalty streams. He advised Northwestern University on the sale of a portion of its worldwide royalty interest in Lyrica for $700 million, the largest monetization ever of a royalty stream for a pharmaceutical product. Mr. Gourary also advised Emory University on its ground-breaking monetization of the royalty rights associated with Emtriva for $540 million, recognized by Investment Dealers' Digest as the 2005 Healthcare Deal of the Year, and helped Centre Solutions, a member of the Zurich Financial Services Group, develop and structure the first pharmaceutical royalty securitization, a $130 million senior/subordinated financing, on behalf of a major university, of the rights associated with the intellectual property at the core of a leading pharmaceutical product.
[back to top]
Daniel Grau
Daniel Grau is CEO and Vice-Chairman of Cortria Corporation, a clinical stage pharmaceutical company focused on creating safe and well-tolerated medicines for the treatment of cardiovascular disease. Mr. Grau is also a member of the Product Advisory Board of Concert Pharmaceuticals and the Advisory Board of Hygeia Therapeutics. Prior to his appointment as CEO of Cortria, Mr. Grau was Chief Operating Officer of CombinatoRx (NASDAQ: CRXX) and a business consultant to Pharmacia Corporation (now Pfizer). Mr. Grau earned his B.A. with High Honors in English Literature from Davidson College, and his M.A., M.A.R., and M.Phil. degrees in Philosophy & Religious Studies from Yale University, where he held an Andrew J. Mellon Fellowship in the Humanities.
[back to top]
David Gulley
David Gulley, PhD, is Associate Vice President for Technology and Economic Development for the University of Illinois campuses (www.uillinois.edu) and Assistant Vice Chancellor for Research at the UI Chicago campus. In these roles he provides leadership in technology-based economic development which includes academic-industry interactions and technology commercialization. David has over 20 years of experience in academic-industry interactions, especially in technology transfer with life science and biopharma industries. Gulley holds an MA from Virginia Tech and a BA and PhD from Southern Illinois University.
[back to top]
Bill Guo
Bill is the Chairman and founder of Venturepharm Group, a leading full service plus pharmaceutical company in Asia, and led its two flag ship Venturepharm lab to become the first CRO Company listed in HK and CBI group, the first Chinese company made acquisition in NSDAQ. He has spent over 9 years global pharmaceutical experiences from researcher to senior executive e.g. Johnson & Johnson, Novapharm and Venturpharm Canada in North American. 8 years of entrepreneurs experiences in China.
After obtained the medical degree in China, Bill went to Canada to pursue his Master and Ph.D (Candidate) Studies with respectively, pharmacokinetics and physical pharmaceuticals from the University of Toronto, MBA from Herriot Watt University and Executive education from Judge Business School, University of Cambridge UK
Fortune magazine recognized him as one of the most potential entrepreneurs in China. He was also recipient of various rewards: 2005 National Hero awarded by the state council of China; One of the Ten best management elites in China in 2004, one of the ten most influential individual in economic field of China, 2005. Distinguished entrepreneur awarded from oversea by government of China, 2005. Sole winner of Youth Chinese Entrepreneur Award organized by Asia Business Week in 2003. 2005 Entrepreneurs and innovation by BCC (British Chamber of Commerce).
[back to top]
Dr. Pradeep Haldar
Dr. Pradeep Haldar (MBA, Ph.D) serves as Director of the Energy & Environmental Technology Applications Center and the Associate Vice President of Energy Programs at the College of Nanoscale Science & Engineering (CNSE) and is Founding Professor and Head of the NanoEngineering Constellation at CNSE, University at Albany, State University at New York (SUNY). He has partnered with several start-up and large companies in technology development initiatives and assisted in overcoming technical, market and business development barriers. Dr. Haldar is involved in technology commercialization through the insertion of nanotechnology innovations in energy and environmental application areas including fuel cells, solar technology, power electronics, superconductors, hydrogen and sensors.
Prior to joining the University at Albany, Dr. Haldar served as General Manager and Technical Director of IGC-SuperPower, LLC and was responsible for the formation and startup of SuperPower, a new subsidiary of Intermagnetics General Corporation. Prior to leading SuperPower, Dr. Haldar was Manager of Advanced Devices and Systems, a Technology Development group at Intermagnetics, in charge of the company's efforts to identify new businesses, emerging markets and technology strategies in electric power, medical and electronic industries. He has over 15 years of diverse technical, marketing and business development experience with increasing responsibilities and has also served as program manager for several large government and commercial programs.
Dr. Haldar is a Fellow of the Institute of Physics and member of professional organizations that include IEEE, MRS, TMS and AIP. He is the author or co-author of over 100 technical papers and has three patents in materials development. Dr. Haldar was awarded the 2002 Business Review's 40 under forty upcoming individuals in New York's Capital Region. He is Vice Chair of DOE's National Clean Energy Incubator Alliance Network. He has led and organized several outreach initiatives including Tech Valley Energy Forum, NY Loves Energy, Power-Gen International Pavilion and New York Fuel Cell Network. He also established and is currently Executive Director of New Energy New York, a consortium of energy related companies in upstate New York. Dr. Haldar has played a key role in developing New York State's Hydrogen Roadmap, Superconductivity outreach programs, and the New York State Solar Roadmap.
[back to top]
Steve Hargrave
Steve Hargrave has been a licensing professional for over
10 years, primarily in high-technology environments. He has negotiated
a large number of licensing agreements, including many dealing directly
with Digital Rights Management. Steve worked for a number of years
in the Corporate Licensing Office at Digital Equipment Corporation,
then the world's second largest computer company. He has also
managed Business and Partner Relationship organizations at Digital
Equipment Corporation, Oberon Software, and Vignette Corporation. At
Bose Corporation he has specific responsibilities for DRM-related licensing
agreements.
[back to top]
Johan L. Hoegstedt
Johan joined AstraZeneca in 1992 after graduating with an MBA in International Business from the University of Utah, and has been in various sales, marketing, and global roles within the US business. In his role as the Vice President of Specialty Care, he was the member of the US Operations and Portfolio Management Team and was responsible for Specialty Care in-line brand teams including Seroquel, Arimidex/Faslodex, Iressa, and Casodex/Zoladex.
In his position as leader of Emerging Specialty Care brands, he was a member of the Global Marketing Senior Management Team under Martin Nicklasson. In this role Johan represented Global Marketing on the Neuroscience and Oncology TAPT's.
Currently, Johan is the Vice President of Strategic Planning Business Development (SPBD) for the US team as well as the Vice President for SPBD on the Neuroscience Therapeutic Area Portfolio Team (TAPT).
Outside of AstraZeneca, Johan is a Board Member on the Swedish American Chamber of Commerce (SACC), is on the Board of Overseers for Penn's Nursing School, and has been involved with the CRO Gold Standard for Cancer Care.
Johan and his wife Jody have three children, Karl, Isabella, and Analie and reside in West Chester, Pennsylvania.
[back to top]
Mark S. Holmes
Mark S. Holmes is the founder and C.E.O. of PatentBridge LLC a privately held patent brokerage firm in Silicon Valley that specializes in select patents covering extraordinary scientific and industrial breakthroughs. He is co-chair of the Silicon Valley Chapter of LES.
Mr. Holmes has advised Visa, Sony, Applied Materials, Intergraph (in its $500,000,000+ settlement in Intergraph vs. Intel), Biosite, Fairchild Semiconductor, Rigel Pharma, Yamanouchi Pharma and the University of California at Berkeley (Berkeley Lab), as well as startups.
Mr. Holmes co-founded a successful startup which was sold to the Alabama state employees retirement fund (RSA) in the late 1990's.
He is also an active angel investor and advisor to technology startups.
He is a registered patent attorney, holds an engineering degree from Brown, is a member of the Institute of Electrical and Electronics Engineers (IEEE), and wrote the book Patent Licensing: Strategy, Negotiation & Forms (PLI).
He speaks nationally on the commercialization of intellectual property for the Practising Law Institute (PLI), Renaissance Weekend, Washington State Patent Law Association, Oregon Patent Law Association and other organizations.
[back to top]
Richard E. Honen
Richard E. Honen, a Partner in the Albany office of Phillips Lytle LLP, focuses his practice in corporate and venture capital law and commercial litigation. He provides corporate counsel to a broad spectrum of companies with a particular emphasis on emerging growth and start-up companies. Mr. Honen has successfully represented companies in a wide variety of commercial litigation matters including shareholder disputes, corporate dissolution actions, and the defense of non-competition agreements.
He has written and lectured extensively on topics of corporate law, venture capital and angel investing to various national and local groups. His publication credits include acting as General Editor for the LexisNexis Practice Insights (LexisNexis Online 2006) and as Editorial Board Member of "White's New York Business Entities" (LexisNexis Matthew Bender 2006). In addition, Mr. Honen was a panelist at the 2006 Angel Capital Education Foundation Summit in New York City and has lectured on related subjects at the National Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) Conference, the Vermont Investors' Forum, The Strategic Research Institute NanoMedicine Conference, and the American Ceramics Society Annual Meeting. He is also a lecturer at various continuing legal education programs sponsored by the New York State Bar Association and other groups.
Mr. Honen is acknowledged to be one of the early practitioners of nanotechnology law in upstate New York, as reported in a March 2003 article in the New York Law Journal. He is also actively involved in educating future entrepreneurs, having lectured on behalf of the Science and Technology Law Center of Albany Law School Smart Start Program, Albany Law School of Union University, Rensselaer Polytechnic Institute and the University at Albany at both the graduate and undergraduate level. Mr. Honen is a graduate of The State University of New York at Albany and Albany Law School of Union University.
[back to top]
Bradley Hulbert
Bradley Hulbert has had substantial experience negotiating and drafting patent licenses over the past 30 years and is the current chair of the LES High Technology Sector. He is a founding partner of McDonnell Boehnen Hulbert & Berghoff, a 75-lawyer IP firm in Chicago, and is also an adjunct professor of law and the Director for Academic and Professional Program Development at the Chicago-Kent Law School.
[back to top]
Don Jarrell
Don Jarrell is President of Austin, Texas-based Digital Thinking Inc, consulting
in IP matters and Product Management. With a combined 17 years at Nortel,
Alcatel and Qwest, and another 10 with numerous clients he has been involved
in a very wide variety of licensing operations and transactions, several
of which were groundbreaking as to organizational change, valuation, royalties,
terms, compliance methods and business operational factors.
[back to top]
D. Brian Kacedon
Brian Kacedon is a member of the firm's Mechanical Practice Group, where
his practice includes patent licensing, patent litigation, patent prosecution,
and patent opinion work.
A substantial portion of his practice includes patent
licensing and related litigation for various technologies used in consumer
electronics products. Mr. Kacedon's role in these matters has included
assisting clients in conducting market assessments for their patents, conducting
licensing negotiations, drafting licensing agreements, and participating fully
in related litigations. Mr. Kacedon also has extensive experience in drafting
patent, know-how, and software license agreements in many other industries.
Mr. Kacedon's practice also includes preparing opinions on patentability,
infringement, and validity, and handling all phases of preparing and prosecuting
patent applications before the U.S. Patent and Trademark Office.
In addition
to practicing law, Mr. Kacedon has lectured widely on licensing. He is currently
an Adjunct Professor teaching licensing at the George Mason University Law
School. For several years he has presented courses for drafting patent and
know-how licenses for the Patent Resources Group as well as other organizations.
He is also active in professional organizations including the Licensing Executives
Society (U.S.A. and Canada), where he currently serves as Secretary of the
High Technology Sector.
Admitted:
2000, Maryland; 2001, District of Columbia;
registered to practice before the U.S. Patent and Trademark Office.
Education:
New York University School of Law (J.D., 2000); Duke University (B.S.M.E.,
cum laude, with distinction, 1997).
Association Involvement:
Maryland Bar
Association; American Intellectual Property Law Association; Licensing Executives
Society.
Representative Publications:
Coauthor, "Patent Trolls: A Stereotype
Causes a Blacklash Against Patents and Licensing," Les
Nouvelles, December
2006.
[back to top]
Michael J. Lasinski
Michael J. Lasinski is a Managing Director at Ocean Tomo and is responsible for
the company's valuation practice. Mr. Lasinski is a recognized
expert in the area of intellectual property (IP) centric transactions and valuation. His
work has focused on IP-based business transactions, including IP portfolio
analysis, target/partner selection, strategic due diligence and other financial
advisory services such as negotiations and transaction/deal structuring and
closure. Post deal, Mr. Lasinski has been involved in several royalty
audits.
Mr. Lasinski has been the financial negotiator for IP-centric transactions
and matters dealing with IP valuation issues. Mr. Lasinski has represented
his clients in arbitration proceedings, litigation, tax matters as well as
other regulatory issues. Industries in which he has experience include
automotive, health care, pharmaceuticals, consumer products, chemicals, food,
software, computer hardware, telecommunications as well as others.
Mr. Lasinski has helped companies strategically manage their IP by creating
global corporate organizations designed to maximize current and future intellectual
property value. This has included the development of global corporate
IP management companies, IP development and filing strategies and licensing
groups.
In addition to intellectual property valuation matters, Mr. Lasinski has
performed appraisals for corporate mergers, acquisitions, tax and financial
reporting purposes.
[back to top]
John R. Leone
Mr. Leone joined Paul Capital Partners in 2007 with over 30 years of pharmaceutical industry experience. Most recently, he was President and Chief Executive Officer of Cambrex Corporation, a leading life sciences company. Previously, Mr. Leone was at Aventis, where he served as Senior Vice President and Chief Operating Officer of all US Commercial Operations. His industry experience also includes both domestic and international executive level management roles with RPR,Wyeth and Pfizer. Mr. Leone received his BS degree in Engineering from the US Military Academy at West Point and his MBA from the University of Colorado.
[back to top]
Kelly Mooney Lester
Kelly Mooney Lester is a Partner in the Capital and Innovation Group of Phillips Lytle LLP. Ms. Lester concentrates her practice in corporate law. She has been a trusted advisor to local executives on issues related to licensing, employment contracts, asset protection, business succession planning and estate litigation. Ms. Lester also provides counsel to a growing number of non-profit organizations whose mission is to support research and technology growth. She is admitted to practice in New York and Florida and is a member of various local, state and national bar associations.
Currently, Ms. Lester serves on the Board of Directors for the Albany Medical Center Foundation and is a member of the Licensing Executives Society. Ms. Lester frequently volunteers to mentor and work with young entrepreneurs. She was one of the founding forces behind the Tech Valley Angels Network (TVAN) and has served as a judge for the Tech Valley Collegiate Business Plan Competition through the Lally School of Management & Technology at RPI as well as for the national Graduate Student Business Plan Competition sponsored by LES. In addition, she served on the Board of Directors of the Capital Region’s Global Business Network is involved with the Women’s Fund of the Capital Region Founding 500 and the Tech Valley Non-Profit Business Council. Ms. Lester is a cum laude graduate of Union College and Albany Law School.
[back to top]
Russell E. Levine, P.C.
Russell Levine currently serves as an International Delegate to the Licensing Executives Society International ("LESI") organization and as Chair of the LESI Patent and Technology Licensing Committee. He also is Program Co-Chair for the LESI 2008 Annual Meeting. He is a past chairman of the LES (USA & Canada) Litigation Committee and past chair of the LES (USA & Canada) Laws and Government Action Committee. Recent LES workshops in which Russell participated include "Experimental Use Rights," at the LESI annual meeting in Zurich; "Top 10 Changes in Patent Litigation Affecting Licensing," at the LES (USA & Canada) Spring meeting in Atlanta; "Top 10 Things You Need to Know About U.S. Patent Litigation," at the LES ANZ annual meeting in Australia; and "Top 10 Court Decisions of 2006 Affecting Licensing," at the LES (USA & Canada) annual meeting in New York. He is a member of the ABA, the AIPLA, the Federal Circuit Bar Association, the International Bar Association, the International Trade Commission Trial Lawyers Association and past chairman of the Young Lawyers Committee of the AIPLA.
Russell has been active throughout his career in civic, charitable and industry organizations. He currently is Vice-Chair and Chair-Elect of the President's Council of Chicago's Museum of Science and Industry and Co-Chair of its Membership Committee. He also serves on the Editorial Board of the "Managing Intellectual Property" monthly publication. For the past 16 years, Russell has taught a course for the Society of Automotive Engineers entitled "Patent Law for Engineers."
Russell was recently invited to become a Master in the Richard Linn American Inn of Court. He also was recently inducted into the International Directly of Distinguished Leadership Hall of Fame for his contributions to the field of Intellectual Property. He also for several years running has been recommended by his peers in a statewide survey by the Leading Lawyers Network to be among the Top Lawyers in Illinois in Intellectual Property.
He holds a B.S. in Interdisciplinary Engineering and a B.S. in Economics, both degrees from the University of Michigan. He received a law degree from the University of Chicago, and he is registered to practice before the United States Patent and Trademark Office. He is admitted to the bars of Illinois, New York, District of Columbia, the U.S. Supreme Court, the Federal, 1st, 2nd, 3rd, 4th, 5th, 6th, 7th and 11th Circuits, the Northern District of Illinois, the Eastern District of Wisconsin and the Eastern District of Michigan.
[back to top]
Roger Longman
Roger Longman is a Managing Partner at Windhover Information Inc. and has been involved with the health care industry for more than 20 years.
In 1983, Longman joined The Wilkerson Group as a writer covering the pharmaceutical and biotech industries for IN VIVO: The Business & Medicine Report. In 1989, Longman along with David Cassak led a buyout of the Wilkerson Group's publications division, which they moved to Connecticut and renamed Windhover Information Inc.
Since then Mr. Longman and Mr. Cassak have launched several new ventures including Start-Up: Windhover's Review of Emerging Medical Ventures, Strategic Intelligence Systems; a web based suite of databases-including the industry's most comprehensive and detailed database of industry M&A, alliances and financings--and a series of senior-executive conferences in corporate strategy, business development, R&D, and finance. In 2004, Windhover acquired Medtech Insight, an information company covering the medical device field through a market-leading newsletter, a series of in-depth market reports, and a number of conferences.
Over the years, Mr. Longman has become recognized as one of the leading experts in pharm/bio dealmaking. He is often asked to speak at many key industry events including the Licensing Executive Society, Biotechnology Industry Organization (BIO) as well as at leading pharma and biotech companies. He lectures regularly at several leading universities. Mr. Longman completed his BA at Cornell University and an MA at the University of North Carolina at Chapel Hill, and then taught for three years at the European division of the University of Maryland.
[back to top]
Robert J. Lopes
Robert is the Chief Technology Officer at ThinkFire Services, USA, Ltd. where he pioneered the development of a custom patent rating system that evolved into ThinkFire’s hallmark patent portfolio evaluation service.
Robert began his career in intellectual property with Lucent’s Intellectual Property Business group as a Senior Patent Manager and Director of reverse engineering.
In addition to management and seasoned IP skills, Robert commands an extensive technical background used in analysis of patent portfolios and is a subject matter expert in the fields of: data communications (networking), consumer electronics, wireless (cellular, fixed) and computer hardware and software. This diversity of technology and patent evaluation expertise is a result of his tenure at Bell Laboratories where he developed many customized (electrical/optical) telecom products including Primary Reference "atomic clocks" used in network synchronization. Robert holds several patents in the areas of computer security, timing systems and wireless location.
Robert holds B.S. and M.S. degrees in Electrical Engineering and is currently an Adjunct Professor of Electrical Engineering at New Jersey Institute of Technology where he teaches a graduate class on "Advanced Microprocessor Systems". Robert is also an electronics and programming mentor for the nationally recognized FIRST robotics challenge.
[back to top]
Amory Lovins
Physicist Amory Lovins is Chairman and Chief Scientist of Rocky Mountain Institute (www.rmi.org) and Chairman Emeritus of Fiberforge, Inc. (www.fiberforge.com). Published in 29 books and hundreds of papers, his work has been recognized by the Blue Planet, Volvo, Onassis, Nissan, Shingo, and Mitchell Prizes, a MacArthur Fellowship, the Benjamin Franklin and Happold Medals, nine honorary doctorates, an Hon. AIA and FRSA, Foreign Membership of the Royal Swedish Academy of Engineering Sciences, and the Heinz, Lindbergh, Right Livelihood, and World Technology Awards. He advises governments and major firms worldwide on advanced energy and resource efficiency, and has led the technical redesign of >$30 billion worth of facilities in 29 sectors to achieve very large energy savings at typically lower capital cost.
[back to top]
Robert S. MacWright
Dr. Robert MacWright is
Executive Director and CEO of the University of Virginia Patent Foundation,
which evaluates, protects, and licenses inventions made at the University
of Virginia. Dr. MacWright also serves as the
CEO of Spinner Technologies, Inc., a subsidiary of the Patent Foundation
that encourages and supports faculty entrepreneurs and the technology-based
start-up companies they form. Dr. MacWright holds
a Ph.D. in biochemistry, and is also a Registered U.S. Patent Attorney. He
formerly practiced law in the IP practice group at Skadden, Arps, Slate, Meagher & Flom,
L.L.P., and also at the IP law firm of Kenyon & Kenyon. Dr. MacWright
has been involved in the university licensing profession since 1985.
[back to top]
David Marston
David Marston is a Partner at PricewaterhouseCoopers LLP where he leads the
U.S. Licensing Management Practice. Mr. Marston focuses on intellectual
property matters, dispute analysis and investigations. Mr. Marston has extensive
experience and expertise in designing and implementing licensing compliance
programs and leads both domestic and international licensing examinations
on behalf of clients in the software, communications, biotechnology, consumer
products and entertainment and media sectors.
[back to top]
William R. Mattson, Jr.
Bill Mattson holds a B.S. in Accounting from Bradley University & an MBA in Marketing from Loyola University. He spent 13 years in executive positions at Abbott Laboratories, initially in the USA & then overseas in the Philippines, Iran, Greece & France.
In 1983, Bill was recruited by Monsanto. He headed up the commercial/strategic planning activity, which moved Monsanto into pharmaceuticals. After the acquisition of Searle & NutraSweet, he assumed the position of Area VP in Searle International until The Mattson Jack Group (MattsonJack) was founded in 1986.
Bill co-founded MattsonJack along with Dr. William Jack. Following the sale of MattsonJack to WPP Group, a $10+ billion UK based professional services holding firm in 2003, Bill retired in 2008.
Bill serves on the Boards of St. Louis College of Pharmacy, Grace Place, & Oscient Pharmaceuticals (based in Boston, MA).
[back to top]
Daniel M. McGavock
Dan McGavock is a Vice President and IP practice leader of CRA International (NASDAQ: CRAI), a business, financial, and economics consulting firm with over 28 worldwide locations spanning 10 countries and 4 continents. CRA's IP practice provides valuation, litigation support/expert testimony, transaction advisory, cross-border transfer pricing, and strategic consulting services related to all types of IP and intangible assets. Dan has specialized in the valuation and strategic management of IP for over 22 years. He has valued IP in a broad array of strategic, regulatory, and transactional contexts and has provided expert testimony on IP damages issues on over 50 occasions. Prior to CRA's acquisition of InteCap in 2004, Mr. McGavock served as InteCap's President and as a member of its Board of Directors. He is also a registered CPA and currently serves as Vice Chairman of LESI's audit committee.
[back to top]
Jeremy Middleton
Jerry joined Elusys in 2007 as Vice President, Corporate Development. Previously, Jerry was Vice President of Business Development at Valera Pharmaceuticals. While at Valera, he led all business development, strategic planning and project planning activities. Prior to Valera, he was with Neose Technologies initially as Director, Commercial Development, then Senior Director, Commercial Development, followed by Vice President, Commercial Development, Manufacturing and Facilities. While there, he was responsible for leading the commercial development, manufacturing and facilities functions, including the development of overall corporate business strategy. Jerry also held various positions with Abbott Labs/BASF Pharma, The Boots Company and Doverstrand Ltd. Jerry holds a BS from DeMontfort University in England.
[back to top]
Nat Milburn
As head of Newell Rubbermaid's External Business Development (EBD) function, Nat is responsible for enabling Newell Rubbermaid's Global Business Units to build their brands through the development of external partnerships. Specifically, Nat and his EBD team lead the Company's global efforts in the acquisition and licensing of brand and technology assets.
Nat Milburn joined Newell Rubbermaid's CEO in February 2005 to establish core licensing functions that protect and leverage the company's intellectual property.
As Vice President of External Business Development, Nat has established a "Best In Class, Built To Last" licensing business model for leveraging the company's IP to further build its brands and drive increment revenue. With Nat's leadership, Newell Rubbermaid now has a focused global licensing team and has developed brand licensing programs for several of the Company's leading brands including Calphalon, Graco, Rubbermaid and Paper Mate. Sales of Newell Rubbermaid license products have grown annually more than 40% in each of the past 3 years under the leadership of Nat and his team. In 2008, retail sales of Newell Rubbermaid's licensed products are expected to exceed $200 million dollars. Newell Rubbermaid also has licenses through its various divisions with numerous well-known licensors such as DreamWorks, Disney, Gatorade, Nickelodeon and The National Hockey League.
Nat's major focus at present is on leveraging the company's portfolio of nearly 1,700 patents to boost innovation and ROI for this R&D and investment.
Prior to Newell Rubbermaid, Nat worked at The Coca-Cola Company to advance its global trademark licensing program. He joined the Company in 1997 as a Regional Licensing Manager, accountable for developing and managing businesses in Asia Pacific, Middle East and Africa, before focusing exclusively on business in North America. He was later named Director of North and Latin American Licensing. In this role, Nat was responsible for 78% of Coca-Cola's worldwide licensing revenue.
Nat graduated with highest honors in Economics with a Bachelor of Arts degree from the University of Tennessee, and graduated with a degree in Japanese language from Sophia University's Japanese Language Institute in Tokyo, Japan.
Nat is a frequent speaker and author on best-in-class licensing practices and administration and was a member of the Licensing Industry Manufacturers Association's (LIMA) Board of Directors from 2004-2006. He has three children and resides in Atlanta, GA.
[back to top]
Tanya K. Moore
Tanya Kaptsan Moore is a General Manager of Outbound IP Licensing in Microsoft's corporate Intellectual Property & Licensing group. Her responsibilities include formulating outbound technology licensing strategies, identifying and negotiating licensing arrangements in various Microsoft technology areas, including financial valuations, and leading a team of licensing executives. In her IP career, she has led and participated in a wide variety of transactions involving the licensing of patents, know-how, copyrighted materials, and trademarks, as well as asset sales, divestitures and joint ventures.
Prior to assuming her position with Microsoft, Ms. Moore was a key member of IBM's Intellectual Property & Licensing organization. Ms. Moore joined IBM in 1980 and spent the early part of her career in software development for a number of IBM's operating systems. She has held numerous technical positions, including project and quality management, where she received many awards. During this time, she also served as an adjunct instructor at IBM's Software Quality Institute. She has held a number of technical management positions in applications and systems software product development, transitioning in the mid-nineties to the business side of IBM, initially in server group OEM sales and later joining the IBM corporate IP group. In late 2003, Ms. Moore left IBM to join the Microsoft IP team.
Tanya Kaptsan Moore holds a Bachelor of Arts degree in Mathematics from Fordham University, and a Master of Science degree in Computer Science from Polytechnic University. Ms. Moore is a member of the Licensing Executives Society (LES), and is the Secretary and Board Member of the LES Foundation, Inc.
[back to top]
Krishnan "Nandu" Nandabalan, Ph.D
Nandu brings 15 years of experience in the biotech sector and has been an entrepreneur in establishing CuraGen (Group Leader, Functional Genomics), Genaissance (VP of Alliances/BD; Exec. Dir, Technology Systems) and Protometrix (Founder and Investor). He has extensive experience in M&A, in/out-licensing, co-development/co-marketing ventures, and setting up service-providing units. He has generated more than $20 million dollars of revenue since 2000 and closed deals with major pharma/biotech companies, e.g., Pfizer, J&J, Pharmacia, Novartis, BMS, BiogenIdec, Millennium, Merck KGaA, Organon, Sankyo, and Otsuka. He is an inventor of nine published patents and over 100 filed patent applications and has published in leading scientific journals such as Science and Cell. Nandu received a Ph.D. in biochemistry and molecular biology from the Indian Institute of Science, Bangalore, India, and was a post-doctoral fellow at Yale University.
[back to top]
Mark Nawacki
Mr. Nawacki joined Paladin in September 2003 and holds responsibility
for all business development activities at Paladin Labs Inc., a leading
Canadian specialty pharmaceutical company. Since joining Paladin,
Mark has concluded over 20 business development deals that are cumulatively
expected to contribute in excess of $100 million in Canada-only annual
revenues at peak. Other key accomplishments include the establishment
of Paladin's Licensing Advisory Board (LAB) and multiple internal
process improvements to improve the deal flow and efficacy of Paladin's
evaluation and execution of business development transactions.
Prior to joining Paladin, Mark held progressively senior leadership
positions at Pharmacia, a global top 10 pharmaceutical company that
is now part of Pfizer Inc. While at Pharmacia, Mr. Nawacki was responsible
for Canadian business development initiatives and was instrumental in the
design and implementation of a portfolio planning process that guided strategic
planning and business development activities.
Mr. Nawacki began his career as a consultant in Arthur Andersen's Canadian
financial advisory services practice, and later spent time in the consumer
packaged goods industry working with Pillsbury where he was responsible for
financial management of the Green Giant business in Canada.
Mr. Nawacki holds a BA in International Relations and Russian and East
European Studies from the University of Toronto (Trinity), MBA also
from the University of Toronto, and is a Canadian-designated Chartered Accountant. He
is an active speaker on the subject of licensing and business development,
sits on the Healthcare Committee of the Licensing Executive Society and is
President of the Canadian Healthcare Licensing Association.
[back to top]
Jack Nightingale
Jack Nightingale has 23 years of business development, product development, strategic planning, executive management, and management consulting experience. He led global business development activities for a $3 billion division of Honeywell for 5 years. As President of a biotechnology company, he was responsible for licensing research technologies and intellectual property to major pharmaceutical and biotechnology companies. Most recently, he has served as a management consultant on business development to leading global pharmaceutical, biotechnology, medical diagnostics, and consumer healthcare companies. Mr. Nightingale received a Bachelor of Arts degree from Harvard University and an M.P.A. in Economics and Public Policy from Princeton University.
[back to top]
Bradley J. Olson
Brad Olson is counsel in the Washington, DC office of Dickstein Shapiro
LLP in the Intellectual Property Practice. Mr. Olson has extensive experience
in patent litigation, including the handling of discovery, motion, and
trial practice, retaining experts and consultants for trial, coordinating
jury focus groups, and preparing witnesses for deposition and trial testimony. He advises clients on patentability, infringement, and validity issues, with an emphasis in the biotechnology and biomedical device fields. He has prepared and negotiated complex intellectual property rights transfer
agreements, including patent litigation settlements, patent licenses, and computer software and hardware agreements. He also has coordinated
patent litigation in several European countries in conjunction with foreign
counsel. PROFESSIONAL ACTIVITIES
Mr. Olson is the current President of the Swedish-American
Chamber of Commerce in Washington, DC, where he assists in furthering business
opportunities between domestic and international corporations. He is an
active member of the American Intellectual Property Law Association, American
Bar Association (Intellectual Property Section), Federal Circuit Bar Association, and the Giles S. Rich American Inn of Court.
ADMISSIONS
Mr. Olson is admitted to practice before the Court of Appeals
for the District of Columbia, U.S. District Court for the District of Columbia, U.S. District Court for the Eastern District of Wisconsin, and U.S. Court of Appeals for the Federal Circuit. He is registered to practice
before the U.S. Patent and Trademark Office.
EDUCATION
Mr. Olson received his B.A. in Biology from the Central Connecticut
State University (1980), and went on to receive an M.S. in Biology from
the University of Connecticut (1985). He was awarded both his Juris Doctorate
degree, with a patent law specialization, and a Master of Intellectual
Property Law degree, from the Franklin Pierce Law Center (1994).
[back to top]
Dwight Olson
Dwight C. Olson is a Certified Licensing Professional, a Sr. IP Advisor to CONSOR, Principal at Intellectual Assets, and Founder of V3Data. Dwight was Executive Vice
President of TAEUS International, a Vice President at Iron Mountain and was founder of
Data Securities International (DSI) acquired by Iron Mountain Inc. the world's largest
record management company in 1997. Mr. Olson has over 40 years of experience in the
computer software industry. He began his career in the research and development of
supercomputers, parallel processing systems and related application architectures in the
60's and 70's.
Mr. Olson is called the "father of technology escrow" and often speaks on the topic of
using technology escrow as a business tool, valuation of software, trusted third parties in
electronic commerce applications on the Internet, and about securities firms using only
electronic records. He has been involved in the start-up of several software companies as
well as serves on the board of several companies.
Mr. Olson is a former President of the Licensing Executives Society (LES), USA and
Canada, with his wife Lois Chaired the 2003 LES San Diego Annual Meeting and he has
served as chair of LES and LESI information technology and Internet committees. He
was an associate member of the American Bar Association's Electronic Commerce Law
and Information Security Committee working on the ABA's Digital Signature
Guidelines.
[back to top]
George Park
George is a Manager of New Initiatives at IPVALUE, a provider of strategic
IP advisory and transaction services for premier technology organizations. He is responsible for partnership development, patent portfolio analysis
and valuation, corporate strategy and marketing, and other business development
efforts.
Prior to IPVALUE, George was a Managing Scientist at Exponent, an engineering
consulting firm, where he worked on defense-related technology development. George also worked as a consultant at McKinsey, where he provided leadership
for such engagements as the identification of IP acquisition targets for
a software vendor and development of a new product line for an IT hardware
manufacturer.
George also served as a Senior Scientist for Arete Associates (a defense
contractor focused on modeling and simulation) and as an Analyst at RAND
(a think tank conducting policy and technology analyses for government
and commercial clients).
George holds a UCLA MBA and a Physics PhD from Stanford.
[back to top]
Joel Parker
Joel Parker
is the Licensing Manager for the Hamilton Sundstrand Corporation
of Windsor Locks, CT. He is a 19 year licensing veteran, having
been involved in primarily aerospace licensing since 1988. Prior
to that, he worked in various engineering functions at Hamilton Standard. Joel holds a B.A. in Environmental Studies from California State
University Dominguez Hills and an M.S. in Environmental Engineering
from the University of Southern California.
[back to top]
Cheryl Perkins
Cheryl Perkins is a thought leader in innovation and a creative catalyst in brand-building initiatives for companies looking for that innovative edge.
In 2006 Business Week magazine chose Cheryl as one of the a Top 25 Champions of Innovation in the world. She was also named as a top executive driving vision within the consumer goods industry (Visionaries 2006) by Consumer Goods Technology magazine.
With over 20 years experience directing growth and innovation, Cheryl most recently served as the Senior Vice President and Chief Innovation Officer for Kimberly-Clark. She ran the company's innovation and enterprise growth organizations, including research and development, engineering, design, new business, global strategic alliances, environment, safety and regulatory affairs, and oversaw innovation processes, systems and tools. She has ten U.S. Patents and several more pending.
Cheryl brings her expertise to Innovationedge, creating new strategic business opportunities for companies seeking a competitive advantage across key businesses to ensure long-term growth and deliver a continuum of sustainable innovative solutions.
Few consultants are able to do what Cheryl does: Identify and transform insights, designs, technologies and capabilities into total solutions and new-to-the-world innovations.
[back to top]
Marshall Phelps
As Microsoft Corp.'s corporate vice president and deputy general counsel for intellectual property, Marshall Phelps supervises Microsoft's intellectual property groups, including those responsible for trademarks, trade secrets, patents, licensing, standards and copyrights. He oversees the company's management of its intellectual property portfolio, which comprises some 3,000 U.S.-issued patents, their foreign counterparts and more than 11,000 trademark registrations worldwide. In addition, Phelps helps lead Microsoft's ongoing work with other companies in the technology industry to broaden awareness of intellectual property issues.
[back to top]
Winfred M. Phillips
Dr. Winfred M. Phillips, Vice President for Research and Director, Professor of Mechanical Engineering, and Don and Ruth Eckis Professor of Biomedical Engineering at the University of Florida, and President of the University of Florida Research Foundation, July 1,1999-present. Dean of the Graduate School at the University of Florida from July 1, 1999 - February 1, 2004. Dean of Engineering and Associate Vice President at the University of Florida from August 1988 - June 1999.
He was Professor of Mechanical Engineering and Head of the School of Mechanical Engineering at Purdue University from 1980-1988; Associate Dean for Research, College of Engineering at The Pennsylvania State University from 1979-1980; Professor of Aerospace Engineering at The Pennsylvania State University from 1978-1980; Acting Chairman for the Intercollegiate Bioengineering Program at The Pennsylvania State University from 1978-1979; and Visiting Professor at the University of Paris from 1976-1977.
Dr. Phillips received his BSME degree from Virginia Polytechnic Institute in Mechanical Engineering, and MAE and DSc degrees from the University of Virginia in Aerospace Engineering.
He is a member of the following professional societies: Fellow, American Society of Mechanical Engineers [Board of Governors, 1994-98, President, 1998-99]; Fellow, American Association for the Advancement of Science; Fellow, American Society for Engineering Education [Past Chair, National Engineering Deans' Council and President, 1996-97]; Fellow, Accreditation Board for Engineering & Technology, Inc. [President, 1995-96]; Fellow, American Astronautical Society; Fellow, American Institute for Medical and Biological Engineering [Chair, College of Fellows, 1994-95, President, 1996-97]; Fellow, Biomedical Engineering Society; Fellow, The New York Academy of Sciences; Fellow, Royal Society for the Arts; American Society for Artificial Internal Organs [Board of Trustees, 1982-92, Secretary-Treasurer, 1985-87, President, 1988-89]; American Physical Society; Fellow, American Institute for Aeronautics and Astronautics; Licensing Executives Society, Inc.; Society of Research Administrators International; International Society of Biorheology and Society of Automotive Engineers.
Dr. Phillips is a member of the Golden Key National Honor Society, Sigma Xi, Tau Beta Pi, Pi Tau Sigma, Phi Kappa Phi and Sigma Gamma Tau.
Dr. Phillips received the American Society of Mechanical Engineers Ralph Coats Roe Medal, the Florida Trend’s 2005 CEO to Watch List, the Southeastern Consortium for Minorities in Engineering Global Messenger Award, the American Society for Engineering Education Benjamin Garver Lamme Award, the American Society of Mechanical Engineers Dedicated Service Award, the Linton E. Grinter Distinguished Service Award from the Accreditation Board for Engineering and Technology, and the National Engineering Award from the American Association of Engineering Societies. He was named Distinguished Hoosier and Sagamore of the Wabash by the Governor of Indiana for distinguished service to the State. He serves on the Enterprise Florida Board, the Southern Technology Council, the Engineering Directorate Advisory Committee of the National Science Foundation, the President’s Committee on the National Medal of Science; and has served as a consultant to numerous industries, universities, and the National Institutes of Health and State Education Boards; corporate director; and reviewer and member of the editorial boards for a number of journals in Mechanical Engineering and Bioengineering. He has served as a member of the Academic Advisory Council for the Industrial Research Institute; and Governor appointee to the Indiana Boiler Board and the Florida High Technology & Industry Council. He has served as Chair of the Board of Governors of the American Association of Engineering Societies, Chair of the Board of Directors of the Southeastern Consortium for Minorities in Engineering, and is currently a member of the Enterprise North Florida Corporation Board and Vice Chair of the Council for Economic Outreach of Gainesville.
He is the author of over 180 research publications. His personal research and teaching interests include mechanical engineering, fluid mechanics and biomedical engineering.
[back to top]
Rory Radding
Rory Radding is a partner in the New York office of Morrison & Foerster and head of its IP Group. Previously, Mr. Radding was a Senior Partner with Pennie and Edmonds LLP. His practice involves litigating diverse patent, trademark, copyright, and trade secret cases before all trial and appellate federal courts throughout the United States and in the USITC. Besides litigation, Mr. Radding is an accomplished negotiator in transnational transactional matters (with an emphasis in Asia), including mergers and acquisitions, the establishment of joint ventures, international and domestic technology transfer, including licensing, as well as collaborative research agreements and equity financing. Mr. Radding also develops and implements global IP strategies. Mr. Radding received his B.A. in Chemistry at Hamilton College in 1971, his J.D. in 1975 at Albany Law School of Union University, is founding chair of the New York State Bar Association IP Section, an active member of several domestic and international associations, a member of the Board of Trustees of Albany Law School and a member of the Advisory Board of the Science and Technology Center of Union University, and listed in The International Who's Who of Business Lawyers.
[back to top]
José Luis Solleiro Rebolledo
José Luis Solleiro Rebolledo, Director of Technology Sector, Universidad Nacional Autonoma de Mexico
Senior researcher at the Center for Applied Science and Technological Development of the National University of Mexico (UNAM) since 2000. Currently, he is National Researcher Level II.
He was founder of the Center for Technological Innovation where he managed the Technology Transfer Office (1984-1991) and the Academic Programs Direction (1991-1993).
He has published more than 150 academic papers in journals, books and proceedings. He has given lectures in undergraduate and graduate programs in institutions of 17 countries. He has directed 18 college-level thesis, 17 at master level and 8 at doctoral level.
He has been consultant for private firms in Mexico, universities, institutions and international organizations in different matters related to innovation management and technology policy.
He has evaluated international programs and projects as well as academic institutions. He has been referee for journals of technology management such as Technovation, International Journal of Technology Management, Electronic Journal of Biotechnology and Problemas del Desarrollo.
Currently, he co-ordinates CamBioTec, a technological collabortion network for Latin America. Since 2005 he is Manager of the Agri-food Area of the Iberoamerican Program of Science and Technology for Development (CYTED).
[back to top]
John Reid
John Reid is Director of Global Alliance Management, Strategic Planning and
Business Development –Neuroscience at AstraZeneca Pharmaceuticals. In
this role, Dr. Reid combines training and experience in drug discovery research
and business development. He also acts as Neuroscience coordinator for
research collaborations in Japan. Previous positions with AstraZeneca
CNS Drug Discovery US include Director of Knowledge Management and Director
of the Molecular Sciences Department, responsible for exploratory research
in Neurology and Psychiatry. Before joining Astra in 1997, he was scientist
and group leader at the Glaxo Institute for Molecular Biology in Geneva, Switzerland,
where he directed research in signal transduction and developed new screening
systems. He started his career in biotechnology in 1981 at Genentech in San
Francisco. Dr. Reid received his Ph. D. from the University of California,
Berkeley and his B. Sc. from UC Davis. Dr. Reid's research career focused
on membrane proteins and signal transduction including the discovery and functional
characterization of novel G-proteins and potassium channels. He has served
as an expert reviewer for several scientific journals, advisor for the European
Commission, and occasional consultant and advisory board member for scientific
events.
[back to top]
Uwe E. Reinhardt
Uwe E. Reinhardt, a native of Germany, has taught at Princeton University since 1968, rising through the ranks from assistant professor of economics to his current position. He has taught courses in both micro- and macro-economic theory and policy, accounting for commercial, private non-profit and governmental enterprises, financial management for commercial and non-profit enterprises, and health economics and policy.
Professor Reinhardt received the Bachelor of Commerce degree from the University of Saskatchewan, Canada in 1964, when he was also awarded the Governor General's Gold Medal as Most Distinguished Graduate of his graduating class at the university. He received the Ph. D. in economics from Yale University in 1970. His doctoral dissertation was entitled Physician Productivity and the Demand for Health Manpower. He has received honorary doctorate degrees from the Medical College of Pennsylvania, from Mount Sinai School of Medicine, City University of New York, and from the College of Optometry of the State University of New York. In 1998, he was honored with the Second Century Award for Excellence in Health Care by the Columbia University School of Nursing. In 2002, readers of Modern Healthcare, a widely read American trade journal devoted to health care, voted him among the top 10 most influential personality in American health policy. In June of 2004, he was honored with the Distinguished Investigator Award by AcademyHealth, the national association of American health services researchers with over 2,000 members.
In 1978, Professor Reinhardt was elected to the Institute of Medicine of the National Academy of Sciences, on whose Governing Council he served from 1979 to 1982. At the Institute, he has served on a number of study panels, among them the Committee on the Implications of For-Profit Medicine, a study panel on Dental Care in the United States, a panel on the Nursing Shortage, the Institute's Committee on Technical Innovation in Medicine and on the Committee on the Implications of a Physician Surplus. He currently serves on the Institute's Board on Health Care Services, which guides the Institute's research in health-services research. He currently serves on the Board of Directors of the International Health Economics Association (iHEA). In 2007, he was elected President of iHEA, for a two-year term.
Professor Reinhardt is a past President of the Association of Health Services Research (now AcademyHealth) on whose Board he served for over a decade. In 2000, he was elected a Distinguished Fellow1 of that organization.
Professor Reinhardt has served on a number of government committees and commissions, among them the National Council on Health Care Technology of the then U.S. Department of Health and Welfare (1979-82) and the Special Medical Advisory Group of the then Veterans Administration (1981-85). From 1986 to 1995 he served three consecutive three-year terms as a Commissioner on the Physician Payment Review Commission (PPRC, now MedPAC), established in 1986 by the Congress to advise it on issues related to the payment of physicians. In 1999, Professor was appointed to the National Advisory Council (NAC) for Health Care Policy, Research and Evaluation for the Agency for Healthcare Research and Quality (AHRQ, formerly AHCPR), U.S. Department of Health and Human Services.
Professor Reinhardt currently is a member of the Council on the Economic Impact of Health Reform, a privately funded group of health experts established to track the economic impact of the current revolution in health-care delivery and cost control. He is also on the Advisory Board of Advisors of the National Institute of Health-Care Management, a Washington-based think tank devoted to issues in managed care. In 1997, he was appointed for a three-year term to the External Advisory Panel for Health, Nutrition and Population of The World Bank, an expert panel that advises The World Bank on its far-flung activities in these areas. In 2000, he was elected as a senior associate of the University of Cambridge, England. Since 1998 he has also chaired the Coordinating Committee of The Commonwealth Fund's International Program in Health Policy. Also in 1998, he was appointed as Commissioner of the Kaiser Commission on Medicaid and the Uninsured. In 2006, the Governor of New Jersey appointed him Chair of the Commission to Rationalize Health Care Resources, which completed its final report in January 2008.
Professor Reinhardt served as Trustee of the Teachers Insurance and Annuity Association (TIAA) from 1978 to 1993. In 2001, he was elected to the Board of Trustees of Duke University, on whose wholly owned Duke University Health System (DUHS) he serves as a Trustee as well. He was recently elected to the Board of Directors of the National Bureau of Economic Research. He currently serves on the Board of Directors of Boston Scientific, Inc., and Amerigroup, Inc.
Professor Reinhardt has been or is a member of numerous editorial boards, among them the Journal of Health Economics, the Milbank Memorial Bank Quarterly, Health Affairs, The New England Journal of Medicine and The Journal of the American Medical Association.
1This honor is distinct from the Distinguished Investigator Award received in 2004.
[back to top]
Kim E. Rosenfield
Kim E. Rosenfield is General Counsel at Stereotaxis, Inc., a publicly traded
company in St. Louis, MO that develops, manufactures, and sells medical
devices and equipment for remote navigation and control in endovascular
procedures through use of magnetics and state-of-the art automation and networking. Kim
was previously VIce President of Commercial Transactions at KV Pharmaceutical. She
has also represented many companies, universities, and individuals
in a wide variety of strategic alliances and licensing transactions in her
years of practice at Mintz, Levin, where she was a member of the Business
and Finance Section. Kim was Vice President of Corporate Development
and General Counsel for BioHorizona Implant Systems, Inc., a University spin-off
company, and has served as counsel for University tech transfer offices,
as well as many start-up companies. Previously, Kim was a litigator
in the US Department of Justice, Criminal Division. A cum laude graduate
of Yale and the University of Virginia Law School, Kim is married to Peter
Einstein, MD, PhD and has four teenaged children.
[back to top]
Douglas Roth
Douglas Roth is a Senior Manager of ipCapital Group. He provides advisory services
to organizations considering transactions that involve IP, including licenses,
asset sales, mergers, and acquisitions, in the telecommunications, electronics,
semiconductor, and consumer product industries.
In many instances, the majority of an organization's value is derived from
its intangible assets. By aligning business, market, product, technology, invention,
IP, and intellectual capital interests, Douglas assists companies that want to
realize IP value by helping them tell their IP story to key stakeholders, the
investment community, partners, and others. More information about his work in
this area is available in a recent publication, “Strategic Licensing:
Securing Value from Innovation.”
Douglas has 12 years of consulting, business development, and marketing
experience in domestic and international markets. Prior to joining ipCapital
Group, Douglas was a director at Teleglobe International, a wholesale provider
of global telecommunications services. While at Teleglobe, he was responsible
for managing the company's business in the South Asian countries of
India, Pakistan, Bangladesh, and Sri Lanka. He also led the company's
efforts in the emerging market of electronic telecommunications exchanges
and leveraging the Internet as a new sales channel. Before joining Teleglobe,
Douglas was a manager at ECI Telecom, a provider of telecommunications solutions
to leading carriers and service providers worldwide. During his tenure at
ECI, he managed several of the company's largest client relationships,
including AT&T, and opened several new markets in emerging countries.
Douglas received a Bachelor of Arts in Economics and Mathematics from Boston
University, where he graduated magna cum laude. He also earned a Master of
Science in Electrical Engineering from Boston University and a Master of
Business Administration, with emphases on Strategic Management and Entrepreneurial
Management from the Wharton School of the University of Pennsylvania.
[back to top]
Jill Rusk
Ms. Rusk is a Director with Navigant Consulting
Inc., where she specializes in intellectual asset consulting, including
both intellectual asset management and intellectual property litigation
services. Ms. Rusk provides companies with various analyses related to
their intellectual assets, including knowledge management, portfolio
management, strategy, competitive analysis, evaluation, process improvement,
license compliance, technology commercialization / monetization, system
design, and dispute resolution. Ms. Rusk has also worked closely with
internal and external legal counsel in many different technical areas,
including intellectual property valuation, legal process reorganization,
transfer pricing considerations, and other specialized intellectual asset
needs.
[back to top]
Edward C. Saltzman
Ed is founder and President of Defined Health, a leading consultancy in business development and disease area strategy for the pharmaceutical industry. Since its founding in 1983, Defined Health has completed thousands of opportunity assessments and commercial forecasts of development stage projects for hundreds of corporate clients across the Big Pharma, Biotechnology and Specialty Pharma complex. Defined Health's length and breadth of experience in evaluating pipeline opportunities provides the firm with a unique and often unconventional spotlight on strategic issues confronting the industry, particularly with respect to the quality of the development pipeline and its implications for sustainability of established and evolving business models.
Ed is a noted speaker on industry strategy and was one of the earliest critics of the Pharma industry blockbuster business model and its over-dependence on in-licensing late-stage primary care blockbuster drugs to fuel growth. Ed was also one of the first to spot the limitation of the specialty pharma serial product acquisition model, and, as a result, he is much sought after for strategic guidance by specialty pharma and biotech companies facing sustainability challenges.
Ed is a member of the Licensing Executives Society and the New York Pharma Forum and is a graduate of New York University.
[back to top]
Jon P. Santamauro
Jon P. Santamauro is Counsel in the Washington, D.C., office of the law firm of Sidley Austin LLP. His focus is on patent law and international intellectual property and trade policy.
Mr. Santamauro joined Sidley Austin after 15 years serving in various government roles. Most recently, Mr. Santamauro was a Patent Attorney in the Office of Intellectual Property Policy and Enforcement (previously known as the Office of International Relations) at the United States Patent and Trademark Office (USPTO), where he was responsible for numerous domestic and international patent law and policy matters. Among other accomplishments, he played a key role in negotiating extensive reforms under the Patent Cooperation Treaty governing the filing and processing of international patent applications and had lead responsibility for matters relating to patent law harmonization. He also had a primary role in issues relating to the relationship of intellectual property, genetic resources and traditional knowledge.
From 2003 to 2006, Mr. Santamauro served as Intellectual Property Attaché in the U.S. Mission to the World Trade Organization (WTO) in Geneva, Switzerland. During this time, he represented the United States at the WTO, World Intellectual Property Organization (WIPO), the World Health Organization (WHO) and other United Nation organizations with respect to matters relating to intellectual property. During his tenure in Geneva, Mr. Santamauro played a key role in negotiations that resulted in agreement by WTO Members on the terms of an amendment to the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement; the first time a core WTO Agreement has been the subject of an amendment.
Previously, Mr. Santamauro worked in USPTO as a patent examiner in the field of digital electronic circuits. He obtained extensive experience in patent examination practice as a Primary Examiner in Technology Center 2800, where he handled complex patent examination matters and was responsible for training of new patent examiners.
Mr. Santamauro is regularly invited to speak on international and domestic patent law and policy matters. He has also served as adjunct faculty at George Mason University Law School.
[back to top]
Mark S. Speers
Mark co-founded Health A |
